戻る
CRISPR Therapeutics AG Stock Declines Amid Mixed Market Performance Ahead of Earnings
戻る
株式ニュース
テーマ
CRISPR Therapeutics AG Stock Declines Amid Mixed Market Performance Ahead of Earnings
AIヘルスケア
CRISPR Therapeutics AG Stock Declines Amid Mixed Market Performance Ahead of Earnings
Edgen Stock
·
Oct 05 2025, 21:40
共有先
共有先
リンクをコピー
ソース:
[1] CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know
[2] CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know | Nasdaq
[3] Crispr Therapeutics stock hits 52-week high at 71.14 USD - Investing.com